Natural Products-Based Drug Design against SARS-CoV-2 Mpro 3CLpro

QR Code

Natural Products-Based Drug Design against SARS-CoV-2 Mpro 3CLpro

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has received global attention due to the serious threat it poses to public health. Since the outbreak in December 2019, millions of people have been affected and its rapid global spread has l...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Rai C. Silva, Humberto F. Freitas, Joaquín M. Campos, Njogu M. Kimani, Carlos H. T. P. Silva, Rosivaldo S. Borges, Samuel S. R. Pita, Cleydson B. R. Santos
Format:	article
Langue:	EN
Publié:	MDPI AG 2021
Sujets:	COVID-19 3CLpro natural products docking molecular dynamics druggability Biology (General) QH301-705.5 Chemistry QD1-999
Accès en ligne:	https://doaj.org/article/aa7b0010d9264ea5af6f74e2be54cb9b
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

QSAR based virtual screening derived identification of a novel hit as a SARS CoV-229E 3CLpro Inhibitor: GA-MLR QSAR modeling supported by molecular Docking, molecular dynamics simulation and MMGBSA calculation approaches
par: R.D. Jawarkar, et autres
Publié: (2022)

Structural and Biochemical Analysis of the Dual Inhibition of MG-132 against SARS-CoV-2 Main Protease (Mpro/3CLpro) and Human Cathepsin-L
par: Elisa Costanzi, et autres
Publié: (2021)

POTENTIAL OF CURATELLA AMARICANA L. AGAINST SARS-COV2: BIOAVAILABILITY, MOLECULAR SIMILARITY AND MOLECULAR DOCKING BETWEEN SECONDARY METABOLITES AND PROTEASE TYPE 3-CHYMOTRYPSIN (3CLPRO)
par: Marcano,Emildo, et autres
Publié: (2021)

Oxidative stress transforms 3CLpro into an insoluble and more active form to promote SARS-CoV-2 replication
par: Liubing Du, et autres
Publié: (2021)

New Acaciin-Loaded Self-Assembled Nanofibers as MPro Inhibitors Against BCV as a Surrogate Model for SARS-CoV-2
par: Mohamad SA, et autres
Publié: (2021)

High-Throughput Screening of Mouse Gene Knockouts Identifies Established and Novel High Body Fat Phenotypes
par: Powell DR, et autres
Publié: (2021)

Molecular docking and dynamics studies on propolis sulabiroin-A as a potential inhibitor of SARS-CoV-2
par: Jaka Fajar Fatriansyah, et autres
Publié: (2022)

MINOR COMPOSITION COMPOUNDS OF ALGERIAN HERBAL MEDICINES AS INHIBITORS OF SARS-CoV-2 MAIN PROTEASE: MOLECULAR DOCKING AND ADMET PROPERTIES PREDICTION
par: Yabrir,B., et autres
Publié: (2021)

Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected Cells
par: David A. Ostrov, et autres
Publié: (2021)

COMPUTATIONAL INVESTIGATION OF METHYL α-D-GLUCOPYRANOSIDE DERIVATIVES AS INHIBITOR AGAINST BACTERIA, FUNGI AND COVID-19 (SARS-2)
par: Kawsar,Sarkar M. A., et autres
Publié: (2021)

Investigation of Thiocarbamates as Potential Inhibitors of the SARS-CoV-2 Mpro
par: Katarzyna Papaj, et autres
Publié: (2021)

Potential role of nicotinamide analogues against SARS-COV-2 target proteins
par: Mandeep Kumar Arora, et autres
Publié: (2021)

Unveiling the Effect of Low pH on the SARS-CoV-2 Main Protease by Molecular Dynamics Simulations
par: Haruna Luz Barazorda-Ccahuana, et autres
Publié: (2021)

Potential of Marine Terpenoids against SARS-CoV-2: An <i>In Silico</i> Drug Development Approach
par: Alaka Sahoo, et autres
Publié: (2021)

Antimicrobial and molecular interaction studies on derivatives of curcumin against Streptococcus pneumoniae which caused pneumonia
par: Li,Liang-Mei, et autres
Publié: (2016)

<i>In Silico</i> Screening of Semi-Synthesized Compounds as Potential Inhibitors for SARS-CoV-2 Papain-like Protease: Pharmacophoric Features, Molecular Docking, ADMET, Toxicity and DFT Studies
par: Mohamed S. Alesawy, et autres
Publié: (2021)

Design of New Quinazoline Derivative as EGFR (Epidermal Growth Factor Receptor) Inhibitor through Molecular Docking and Dynamics Simulation
par: Herlina Rasyid, et autres
Publié: (2020)

CoMFA, Molecular Docking and Molecular Dynamics Studies on Cycloguanil Analogues as Potent Antimalarial Agents
par: Isman Kurniawan, et autres
Publié: (2020)

Repurposing benzimidazole and benzothiazole derivatives as potential inhibitors of SARS-CoV-2: DFT, QSAR, molecular docking, molecular dynamics simulation, and in-silico pharmacokinetic and toxicity studies
par: Ranjan K. Mohapatra, et autres
Publié: (2021)

Sulphated polysaccharides from seaweeds as potential entry inhibitors and vaccine adjuvants against SARS-CoV-2 RBD spike protein: a computational approach
par: Mountasser Douma, et autres
Publié: (2021)

SPECTROSCOPIC AND MOLECULAR DOCKING STUDIES ON THE INTERACTION OF DIMETRIDAZOLE WITH HUMAN SERUM ALBUMIN
par: ZHANG,WANJU, et autres
Publié: (2013)

Study on the mechanism of Guizhi Fuling pill in the treatment of ovarian cancer based on network pharmacology and molecular docking
par: Xiao-Qing Wu, et autres
Publié: (2021)

Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2
par: Ahmed A. Al-Karmalawy, et autres
Publié: (2021)

89Zr-Labeled Multifunctional Liposomes Conjugate Chitosan for PET-Trackable Triple-Negative Breast Cancer Stem Cell Targeted Therapy
par: Yang R, et autres
Publié: (2020)

Identification of key structural features of phosphate and thiophosphate tricyclic coumarin analogs as STS inhibitors
par: Srimathi Radha, et autres
Publié: (2021)

Engineering of Ocriplasmin Variants by Bioinformatics Methods for the Reduction of Proteolytic and Autolytic Activities
par: Roghayyeh Baghban, et autres
Publié: (2021)

A new series of 2,4-thiazolidinediones endowed with potent aldose reductase inhibitory activity
par: Sever Belgin, et autres
Publié: (2021)

Bioactive compounds as a potential inhibitor of colorectal cancer; an insilico study of Gallic acid and Pyrogallol
par: Debanjan Mitra, et autres
Publié: (2021)

Determination of Antibacterial Properties of Some Sulfonamide Compounds by Molecular Docking
par: Hilal Öztürk, et autres
Publié: (2021)

Mechanism of Tongxie Yaofang in the treatment of colorectal cancer based on network pharmacology and molecular docking
par: Ling-Xia Yang, et autres
Publié: (2021)

Pharmakinetics studies, molecular docking and discovery of anti- proliferative agents and its targeting EGFR inhibitors
par: Palanisamy Prakash, et autres
Publié: (2022)

SYNTHESIS, X-RAY CRYSTALLOGRAPHY, MOLECULAR DOCKING AND BIOLOGICAL SCREENING OF 2-AMINOPHENOL BASED SCHIFF BASES
par: ASLAM,MUHAMMAD, et autres
Publié: (2013)

Study on the Mechanism of Baimai Ointment in the Treatment of Osteoarthritis Based on Network Pharmacology and Molecular Docking with Experimental Verification
par: Yingyin Zhu, et autres
Publié: (2021)

An integrated method for optimized identification of effective natural inhibitors against SARS-CoV-2 3CLpro
par: Qi Liao, et autres
Publié: (2021)

Computational studies by molecular docking of some antiviral drugs with COVID-19 receptors are an approach to medication for COVID-19
par: Abdellatiif Magda H., et autres
Publié: (2021)

DFT and Molecular Docking Investigation of Potential Anticancer Properties of Some Flavonoids
par: EHIMEN ANNASTASIA ERAZUA, et autres
Publié: (2019)

In Silico Studies of Two Biphenyl Based Oxime Containing Ligands
par: Bülent Dede, et autres
Publié: (2021)

Theoretical Exploring of a Molecular Mechanism for Melanin Inhibitory Activity of Calycosin in Zebrafish
par: Nilupaier Tayier, et autres
Publié: (2021)

Synthesis, Molecular Docking, and Evaluation of Some New Curcumin Analogs as Antimalarial Agents
par: Endang Astuti, et autres
Publié: (2021)

Standardization of Berberis aristata DC and Nigella sativa L. Using HPTLC and GCMS and Their Antineoplasia Activity in 7,12-Dimethylbenz[a]anthracene-Induced Mouse Models
par: Mohd Mazhar, et autres
Publié: (2021)